2BB score and signals
Foghorn Therapeutics Inc.’s current 2BB score is 24 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 8 | Very Low |
| Momentum | 59 | Stable |
| Financial strength | 21 | Weak |
| Quality | 100 | Very Strong |
| Risk | 55 | Moderate |
Company facts
| Founded | 2015 |
| Employees | 106 |
| 52-week range | $3.27 – $6.95 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-03 | — | -0.2403 | — | $7.23M |
| 2026-08-11 | — | -0.261 | — | $6.11M |
| 2026-05-07 | -0.29 | -0.3111 | $3.27M | $7.59M |
| 2026-03-11 | -0.34 | -0.2523 | $9.25M | $9.69M |
Related companies
2BBBullish & Bearish